CEO Sam Cobb presents to the Morgans Network

AdAlta Chief Executive Officer Sam Cobb presented to the Morgans network in July 2018, providing an update on the company’s lead drug treatment AD-214, the securing of key manufacturing partners and the potential to expand AdAlta’s pipeline us the novel i-body platform.